Literature DB >> 7947038

Renal involvement in tuberous sclerosis complex: a retrospective survey.

L B Zimmerhackl1, M Rehm, K Kaufmehl, G Kurlemann, M Brandis.   

Abstract

In a retrospective survey performed in Germany and Switzerland, 207 patients (ranging in age from newborn to 70 years) were evaluated in order to establish the frequency, prognosis and diagnostic awareness of kidney involvement in the tuberous sclerosis complex. Renal manifestations were observed in 48% of patients: renal cysts (33 patients), renal angiomyolipoma (AML) (30 patients), a combination of both (8 patients), renal cell carcinoma (3 patients), life-threatening events such as haemorrhage (4 patients), hypertensive crisis (2 patients) and chronic renal failure (10 patients) were also documented. The diagnostic imaging techniques of ultrasonography, intravenous urography, computed tomography and magnetic resonance imaging (MRI) are important but do not always yield definitive information. Differentiation between AML and cysts can be achieved using special MRI techniques (RARE). The potential for renal involvement should be monitored in all patients with the tuberous sclerosis complex.

Entities:  

Mesh:

Year:  1994        PMID: 7947038     DOI: 10.1007/bf00856529

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  34 in total

1.  The phakomatoses as paracrine growth disorders (paracinopathies).

Authors:  B G Kousseff
Journal:  Clin Genet       Date:  1990-02       Impact factor: 4.438

2.  Origin of the neuron-like cells in tuberous sclerosis tissues.

Authors:  W G Johnson; H Yoshidome; E S Stenroos; M M Davidson
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

3.  Imaging of tuberous sclerosis lesions outside of the central nervous system.

Authors:  A D Hoffman
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

4.  RARE-MR-urography in the diagnosis of upper urinary tract abnormalities in children.

Authors:  G Sigmund; B Stoever; L B Zimmerhackl; A Frankenschmidt; E Nitzsche; J U Leititis; F E Struwe; J Hennig
Journal:  Pediatr Radiol       Date:  1991

5.  The value of investigation for genetic counselling in tuberous sclerosis.

Authors:  A E Fryer; A H Chalmers; J P Osborne
Journal:  J Med Genet       Date:  1990-04       Impact factor: 6.318

6.  [Giant bleeding angiomyolipoma of the kidney in tuberous sclerosis].

Authors:  H Brandt; C Fischer; H K Deininger; O Hallwachs
Journal:  Rofo       Date:  1989-05

7.  Evidence for genetic heterogeneity in tuberous sclerosis.

Authors:  J R Sampson; J R Yates; L A Pirrit; P Fleury; I Winship; P Beighton; J M Connor
Journal:  J Med Genet       Date:  1989-08       Impact factor: 6.318

8.  Family studies in tuberous sclerosis. evaluation of apparently unaffected parents.

Authors:  S B Cassidy; R A Pagon; M Pepin; J D Blumhagen
Journal:  JAMA       Date:  1983-03-11       Impact factor: 56.272

9.  Angiomyolipoma causing life-threatening hematuria in a child with tuberous sclerosis.

Authors:  A F Azmy; J Stephenson; M Ziervogel
Journal:  J Pediatr Surg       Date:  1989-12       Impact factor: 2.545

10.  A third gene locus for tuberous sclerosis is closely linked to the phenylalanine hydroxylase gene locus.

Authors:  R Fahsold; H D Rott; P Lorenz
Journal:  Hum Genet       Date:  1991-11       Impact factor: 4.132

View more
  3 in total

1.  Association between the growth rate of renal cysts/angiomyolipomas and age in the patients with tuberous sclerosis complex.

Authors:  Jeng-Dau Tsai; Chang-Ching Wei; Shan-Ming Chen; Ko-Huang Lue; Ji-Nan Sheu
Journal:  Int Urol Nephrol       Date:  2014-03-30       Impact factor: 2.370

2.  Nephron-sparing resection of angiomyolipoma after sirolimus pretreatment in patients with tuberous sclerosis.

Authors:  Michael Staehler; Matthias Sauter; Andreas Helck; Ulrich Linsenmaier; Lutz Weber; Karin Mayer; Michael Fischereder
Journal:  Int Urol Nephrol       Date:  2012-09-28       Impact factor: 2.370

3.  Nox4 is a Target for Tuberin Deficiency Syndrome.

Authors:  Qian Shi; Suryavathi Viswanadhapalli; William E Friedrichs; Chakradhar Velagapudi; Cédric Szyndralewiez; Shweta Bansal; Manzoor A Bhat; Goutam Ghosh Choudhury; Hanna E Abboud
Journal:  Sci Rep       Date:  2018-02-28       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.